VITALE, CHIARA
 Distribuzione geografica
Continente #
EU - Europa 5.679
AS - Asia 265
SA - Sud America 29
NA - Nord America 18
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.994
Nazione #
IT - Italia 5.672
SG - Singapore 105
CN - Cina 71
VN - Vietnam 63
BR - Brasile 16
US - Stati Uniti d'America 14
AR - Argentina 7
HK - Hong Kong 7
ID - Indonesia 6
JO - Giordania 3
CO - Colombia 2
EC - Ecuador 2
GE - Georgia 2
IQ - Iraq 2
MX - Messico 2
PK - Pakistan 2
PL - Polonia 2
RU - Federazione Russa 2
ZA - Sudafrica 2
BO - Bolivia 1
CL - Cile 1
CR - Costa Rica 1
GB - Regno Unito 1
IN - India 1
JM - Giamaica 1
JP - Giappone 1
LT - Lituania 1
OM - Oman 1
SA - Arabia Saudita 1
UA - Ucraina 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.994
Città #
Genova 3.393
Genoa 1.360
Rapallo 501
Vado Ligure 402
Singapore 29
Beijing 23
Ho Chi Minh City 23
Bordighera 14
Hanoi 10
Ashburn 6
Da Nang 6
Hong Kong 5
Haiphong 4
Amman 3
Thái Nguyên 3
Tianjin 3
Baghdad 2
Hangzhou 2
Hải Dương 2
Jakarta 2
Los Angeles 2
Lấp Vò 2
Milan 2
Surabaya 2
São Paulo 2
Tbilisi 2
Warsaw 2
Alagoinhas 1
Ananindeua 1
Armação dos Búzios 1
Bila Tserkva 1
Biên Hòa 1
Bogotá 1
Bắc Giang 1
Bến Cầu 1
Can Tho 1
Clorinda 1
Concepción 1
Córdoba 1
Denver 1
Dumont 1
Durban 1
Eunápolis 1
Faisalabad 1
Foz do Iguaçu 1
Gjilan 1
Guayaquil 1
Hefei 1
Jacó 1
Johannesburg 1
Karachi 1
Krasnoyarsk 1
La Paz 1
Lanús 1
León 1
Llambí Campbell 1
Maceió 1
Makassar 1
Marília 1
Mexico City 1
Muscat 1
Nanjing 1
Nha Trang 1
Orem 1
Phoenix 1
Phú Thọ 1
Phủ Lý 1
Poplar 1
Pouso Alegre 1
Quito 1
Quảng Ngãi 1
Quận Bình Thạnh 1
Redenção 1
Rio de Janeiro 1
Rio do Sul 1
Riyadh 1
Salvador 1
San Jose 1
Santa Fe 1
Shenyang 1
Tai'an 1
Taizhou 1
Tokyo 1
Tomsk 1
Uberlândia 1
Vadodara 1
Villa Ballester 1
Villa Mercedes 1
Vĩnh Tường 1
Vũng Tàu 1
Totale 5.870
Nome #
Human NK cells at early stages of differentiation produce large amounts of CXCL8 and express CD161 molecule that that functions as an activating receptor 184
Human natural killer cells: news in the therapy of solid tumors and high-risk leukemias 174
IL-1β inhibits ILC3 while favoring NK-cell maturation of umbilical cord blood CD34(+) precursors 170
Human innate lymphoid cells 169
CD34+ hematopoietic precursors are present in human decidua and differentiate into natural killer cells upon interaction with stromal cells. 163
Phenotypic and functional analysis of the HLA-class I-specific inhibitory receptors of natural killer cells isolated from peripheral blood of patients undergoing bone marrow transplantation from matched unrelated donors. 162
MSC and innate immune cell interactions: A lesson from human decidua 158
"Physiological and Pathological Aspects of Human NK Cells" 156
Human CD8+ T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations. 155
Methylprednisolone induces preferential and rapid differentiation of CD34+ cord blood precursors toward NK cells. 154
Surface expression and function of p75/AIRM-1 or CD33 in acute myeloid leukemias: Engagement of CD33 induces apoptosis of leukemic cells 152
NK Cells and Other Innate Lymphoid Cells in Hematopoietic Stem Cell Transplantation 151
Cytolytic T lymphocytes displaying Natural Killer (NK)-like activity. Expression of NK-related functional receptors for HLA class I molecules (p58 and CD94) and inhibitory effect on the TCR-mediated target cell lysis or lymphokine production 150
Effect of superantigens on human thymocytes: selective proliferation of V beta 2+ cells in response to toxic shock syndrome toxin-1 and their deletion upon secondary stimulation 145
Regulation of myeloid cell proliferation and survival by p75/AIRM1 and CD33 surface receptors. 145
Il-1β-Releasing human acute myeloid leukemia blasts modulate natural killer cell differentiation from cd34+ precursors 142
Effect of tyrosin kinase inhibitors on NK Cell and ILC3 development and function 142
HLA class I-specific inhibitory receptors in human T lymphocytes: interleukin 15-induced expression of CD94/NKG2A in superantigen- or alloantigen-activated CD8+ T cells. 140
Analysis of the circulating Th1/Th17 lymphocyte repertoire after hematopoietic stem cell transplant may reveal opportunistic fungal infections rather than GvHD reaction 140
Expression of HLA class I-specific inhibitory receptors in human cytolytic T lymphocytes: a regulated mechanism that controls T-cell activation and function. 139
HLA-class I-specific inhibitory receptors of NK type on a subset of human T cells. 137
Engagement of p75/AIRM1 or CD33 inhibits the proliferation of normal or leukemic myeloid cells 136
Analysis of the activating receptors and cytolytic function of human Natural Killer cells undergoing in vivo differentiation after allogeneic bone marrow transplantation 132
Cytokine-induced expression of killer inhibitory receptors in human T lymphocytes 130
Plasticity of NK-cell differentiation 128
Human Natural Killer cells undergoing in vivo differentiation after allogeneic bone marrow transplantation: analysis of the surface expression and function of activating NK receptors. 127
Molecular analysis of the methylprednisolone-mediated inhibition of NK-cell function: evidence for different susceptibility of IL-2- versus IL-15-activated NK cells 126
Killer Ig-Like Receptors (KIRs): Their Role in NK Cell Modulation and Developments Leading to Their Clinical Exploitation 121
HLA class-I-specific inhibitory receptor in human T lymphocytes: interference with T-cell functions 119
Isolation, Expansion, and Characterization of Natural Killer Cells and Their Precursors as a Tool to Study Cancer Immunosurveillance 119
HLA-class I-specific inhibitory receptors in human cytolytic T lymphocytes: molecular characterization, distribution in lymphoid tissues and co-expression by individual T cells 118
Human decidua contains NK cell committed CD34+ hematopoietic precursors able to differentiated into functional Natural Killer cells 115
In vivo generation of patient-specific cytotoxic T cell clones (CTL), following donor lymphocyte infusions (DLI) for chronic myeloid leukemia after HLA genotypically identical BMT 114
Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor. 110
The corticosteroid-induced inhibitory effect on NK cell function reflects downregulation and/or disfunction of triggering receptors involved in natural cytotoxicity. 110
Expression of HLA class I-specific inhibitory receptors by chronically activated cytolytic T lymphocytes: useful or harmful to the host? 109
CXCL8 production and absence of LFA-1 surface expression identify human NK cells at early stages of differentiation characterized by CD161 molecule with activating function 108
p75/AIRM1 and CD33, two sialoadhesin receptors that regulate the proliferation or the survival of normal and leukemic myeloid cells 108
Inhibitory receptors sensing HLA-G1 molecules in pregnancy: decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor 105
In vivo generation of patient-specific cytotoxic T cell clones (CTL), following donor lymphocyte infusions (DLI) for chronic myeloid leukemia after HLA genotypically identical BMT 101
Analysis of KIR expression in NK cells recovery after MUD or SIB BMT 100
Human innate lymphoid cells: Their functional and cellular interactions in decidua 100
EZH1/2 Inhibitors Favor ILC3 Development from Human HSPC-CD34+ Cells 96
Transforming growth factor-beta-induced expression of CD94/NKG2A inhibitory receptors in human T lymphocytes 91
Murine models to study human NK cells in human solid tumors 66
Targeted therapies: Friends or foes for patient's NK cell-mediated tumor immune-surveillance? 66
Cord Blood-Derived Natural Killer Cell Exploitation in Immunotherapy Protocols: More Than a Promise? 60
Guadecitabine impact on phenotype and function of peripheral blood and hematopoietic stem cell-derived NK: in vitro differentiation and proliferation 51
MAiS: Exploiting JADE as a Multi-agent Simulator of the Immune System 3
Totale 6.097
Categoria #
all - tutte 19.768
article - articoli 17.290
book - libri 0
conference - conferenze 1.260
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.218
Totale 39.536


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021232 0 0 0 0 0 28 22 45 33 37 30 37
2021/2022569 23 37 39 52 18 40 23 139 32 50 33 83
2022/2023588 48 58 8 57 87 112 1 40 82 1 88 6
2023/2024330 18 34 9 57 30 40 18 19 28 10 10 57
2024/2025976 16 60 27 76 153 88 74 185 39 40 104 114
2025/2026714 221 24 69 96 266 38 0 0 0 0 0 0
Totale 6.097